37it 



TYPHOID 

 therapy 



forty-eight patients positive 

 for E. typhosa injected with 

 anti-typhoid vaccine, 517; 

 protein (deutero-albumose) 

 parenteral admin., 71; with 

 intravenous in j . of albumose, 

 61 ; with IdLlled ciiltures of 

 B. pyocyaneus , 20; with 

 pyrifer, in children, 533, 

 57^; with vaccine, 6k, 72 

 tolerance to action of endotoxins 

 of enteric bacilli in conval- 

 escents, 666, toxic effects 

 of somatic antigens of enteric 

 bacilli in convalescents, 598 

 toxin, pyrogenic action of ana- 



phylatoxin, 51 

 vaccine, ACTH-like effect of fevej; 

 in malignant liypertension, 661 

 adrenals, cortex after, 619; 

 desoxycorticosterone no pro- 

 tection after, 30O; effect of 

 adrenalectomy on leukocjrte 

 level after, 537 

 amidopyrine, for prevention of 



fever, after, 470 

 anaplxylaxis, fatal, after, k26 

 antibody formation after, 601 

 augmentation of effects by 



homologous plasma, 523, 636 

 bacteria, removal from splanch- 

 nic area after, 762 

 cardiac enlarganent during 



therapy by, 463; output, during 

 fever, I56 

 chills after therapy, use of CaCl 



for, 296 

 circulation, alterations, during 

 chill and fever, kl6; cerebral, 

 605; capillary flow during 

 therapy, 155; hepatic blood 

 flow, 478 

 continuous, combined -^'Tith 

 penicillin, in paresis, 594; 

 in ophthalmic conditions, 567 

 effect on hunger and appetite, 74 

 fever after, 72, I56, 229, 264, 



276. See also: Fever 

 fever, controlled, after triple 

 vaccine adminis., 359; effect 

 of expanding dose, 33I; 



modified by direct heat or 

 cold, 78; prolonged, 668 

 hemorrhagic-necrotic activity, 

 toxicity, enhanced by thoro- 

 trast, 472 

 hypothalmic lesions, effect on : 



fever after, 289 

 intraimiscular, combined with 



massive salicylate therapy, 496 

 intraperitoneal, 318 

 intravenous, 72, 27O, 473; drip, 



375 

 leukocytes after, 523^ 537, 601, 



619, 636 

 metabolic rate after, in neuro- 

 syphilis, 229 

 method for assaying steroids 

 and adrenal extract for pro- 

 tective activity against, 449 

 oxygen consumption after, 605 

 -paratyphoid, 'necrosin' yields 

 'pyrexin' after enzymatic 

 degradation, 427; 'pyrexin' 

 thermostable, nontoxic sub- 

 stance, 401 

 renal function affected by, 382, 



561 

 respiration during fever caused 



by, 4l6 

 sediEient, polyvalent, in therapy 



of typhoid, 63 

 therapy in arthritis, 66, 75, 

 82, 94, 191, rheumatoid, 313; 

 asthma, 637; chorea, 313; 

 dermatoses, 95, 473; gonorrhea, 

 391 ; herpes zoster, 473; hyper- 

 tension, 420, 661 ; infections, 

 6I; neurologic disease, 5^2; 

 neurosyphilis, 12, 229, 59^, 

 609; nonspecific. See Protein, 

 therapy, nonspecific; opthal- 

 mic, 135, 5^7; sarcoma, 180, 

 233; shock, 46l; vascular dis- 

 orders, peripheral, l44; 

 thromboangiitis obliterans, 



333, 335 



therapy, mechanism, 110; prefer- 

 red as agent, 76; X-Ray, 

 enhancement by, in leukemia, 

 424 



toxicity, 449; damage to visual 

 organs, 588; dangers, 516, 

 609; enhanced by thorotrast, 

 472; fatal, 426 



